Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-12-28 Sale |
2022-12-30 4:10 pm |
REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director |
5,758 | $714.11 | $4,111,822 | 1,093 (Direct) |
View |
2022-12-12 Sale |
2022-12-13 4:13 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
264 | $730.17 | $192,765 | 19,244 (Indirect Direct) |
View |
2022-12-08 Sale |
2022-12-12 4:35 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
218 | $779 | $169,822 | 5,823 (Direct) |
View |
2022-12-01 Sale |
2022-12-02 4:07 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $758.17 | $75,817 | 19,282 (Direct) |
View |
2022-12-01 Sale |
2022-12-02 4:06 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $756.19 | $831,809 | 29,632 (Indirect Direct) |
View |
2022-12-02 Sale |
2022-12-02 4:05 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
610 | $756.66 | $461,564 | 35,794 (Indirect Direct) |
View |
2022-11-23 Sale |
2022-11-25 1:07 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
11,972 | $740.75 | $8,868,260 | 31,643 (Indirect Direct) |
View |
2022-11-15 Sale |
2022-11-16 4:01 pm |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
3,720 | $727.81 | $2,707,467 | 61,400 (Indirect Direct) |
View |
2022-11-08 Sale |
2022-11-10 4:00 pm |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
4,495 | $754.44 | $3,391,191 | 14,793 (Indirect Direct) |
View |
2022-11-07 Sale |
2022-11-08 4:00 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
7,886 | $745.4 | $5,878,263 | 31,643 (Indirect Direct) |
View |
2022-11-04 Sale |
2022-11-07 4:05 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $727.82 | $727,820 | 30,732 (Indirect Direct) |
View |
2022-11-01 Sale |
2022-11-03 4:03 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $755.89 | $75,589 | 19,382 (Direct) |
View |
2022-11-01 Sale |
2022-11-02 4:04 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
482 | $758.06 | $365,386 | 38,294 (Indirect Direct) |
View |
2022-11-01 Sale |
2022-11-02 4:03 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $750 | $825,000 | 31,732 (Indirect Direct) |
View |
2022-10-17 Sale |
2022-10-18 4:06 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
358 | $739.5 | $264,741 | 40,294 (Indirect Direct) |
View |
2022-10-05 Sale |
2022-10-07 4:03 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
1,844 | $749 | $1,381,156 | 27,979 (Indirect Direct) |
View |
2022-10-03 Sale |
2022-10-05 4:11 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $705.39 | $775,929 | 32,832 (Indirect Direct) |
View |
2022-10-03 Sale |
2022-10-05 4:10 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
3,346 | $724 | $2,422,504 | 29,823 (Indirect Direct) |
View |
2022-10-03 Sale |
2022-10-05 4:10 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $726.54 | $72,654 | 19,482 (Direct) |
View |
2022-09-29 Sale |
2022-10-03 4:05 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director |
10,838 | $702.24 | $7,610,844 | 12,921 (Direct) |
View |
2022-09-12 Sale |
2022-09-13 4:04 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
4,696 | $716.38 | $3,364,111 | 31,643 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-01-03 Option Award |
2023-01-05 4:14 pm |
N/A 2033-01-03 |
REGENERON PHARMACEUTICALS INC. | REGN | Thompson Craig B. Director |
517 | $0 | 796 (Direct) |
View |
2022-12-28 Exercise |
2022-12-30 4:10 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director |
3,613 | $482.68 | 1,093 (Direct) |
View |
2022-12-28 Exercise |
2022-12-30 4:10 pm |
N/A 2030-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director |
5,758 | $0 | 1,093 (Direct) |
View |
2022-12-28 Exercise |
2022-12-30 4:10 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director |
2,145 | $374.12 | 1,093 (Direct) |
View |
2022-12-20 I |
2022-12-21 5:45 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Director |
30 | $728.86 | 479,157 (Indirect) |
View |
2022-12-20 I |
2022-12-21 5:45 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Director |
111 | $729.71 | 479,157 (Indirect) |
View |
2022-12-16 Option Award |
2022-12-20 5:44 pm |
N/A 2032-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Director |
17,905 | $0 | 495,552 (Direct) |
View |
2022-12-16 Option Award |
2022-12-20 4:09 pm |
N/A 2032-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
17,817 | $0 | 48,968 (Direct) |
View |
2022-12-16 Option Award |
2022-12-20 4:08 pm |
N/A 2032-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
5,164 | $0 | 67,582 (Direct) |
View |
2022-12-16 Option Award |
2022-12-20 4:08 pm |
N/A 2032-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
19,367 | $0 | 80,275 (Direct) |
View |
2022-12-16 Option Award |
2022-12-20 4:07 pm |
N/A 2032-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
13,944 | $0 | 33,188 (Direct) |
View |
2022-12-16 Option Award |
2022-12-20 4:07 pm |
N/A 2032-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
12,911 | $0 | 41,033 (Direct) |
View |
2022-12-16 Option Award |
2022-12-20 4:07 pm |
N/A 2032-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
18,075 | $0 | 47,316 (Direct) |
View |
2022-12-16 Option Award |
2022-12-20 4:06 pm |
N/A 2032-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
9,037 | $0 | 36,769 (Direct) |
View |
2022-12-09 Tax Withholding |
2022-12-13 4:13 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
274 | $753.28 | 19,244 (Direct) |
View |
2022-12-09 Tax Withholding |
2022-12-13 4:12 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
492 | $753.28 | 28,122 (Direct) |
View |
2022-05-24 Gift |
2022-12-13 4:12 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Director |
24,040 | $0 | 477,647 (Direct) |
View |
2022-12-09 Tax Withholding |
2022-12-13 4:12 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Director |
57 | $753.28 | 477,647 (Direct) |
View |
2022-12-09 Tax Withholding |
2022-12-13 4:12 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
492 | $753.28 | 60,908 (Direct) |
View |
2022-11-08 Gift |
2022-12-13 4:11 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
330 | $0 | 62,418 (Direct) |
View |
2022-12-09 Tax Withholding |
2022-12-13 4:11 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
466 | $753.28 | 62,418 (Direct) |
View |
2022-12-09 Tax Withholding |
2022-12-13 4:10 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
492 | $753.28 | 31,151 (Direct) |
View |
2022-12-09 Tax Withholding |
2022-12-13 4:09 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
247 | $753.28 | 27,271 (Direct) |
View |
2022-10-26 Gift |
2022-12-13 4:09 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
1,742 | $0 | 27,271 (Indirect) |
View |
2022-12-08 Exercise |
2022-12-12 4:35 pm |
N/A 2028-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
218 | $0 | 5,823 (Direct) |
View |
2022-12-08 Exercise |
2022-12-12 4:35 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
218 | $380.95 | 5,823 (Direct) |
View |
2022-12-08 Exercise |
2022-12-12 4:34 pm |
N/A 2026-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
3,000 | $0 | 33,041 (Direct) |
View |
2022-12-09 Tax Withholding |
2022-12-12 4:34 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
492 | $753.28 | 33,041 (Direct) |
View |
2022-12-08 Tax Withholding |
2022-12-12 4:34 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
2,261 | $768.54 | 33,041 (Direct) |
View |
2022-12-08 Exercise |
2022-12-12 4:34 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
3,000 | $381.92 | 33,041 (Direct) |
View |
2022-12-01 Exercise |
2022-12-02 4:06 pm |
N/A 2029-12-11 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $0 | 29,632 (Direct) |
View |
2022-12-01 Exercise |
2022-12-02 4:06 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $372.46 | 29,632 (Direct) |
View |
2022-12-01 Tax Withholding |
2022-12-02 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
1,890 | $760.35 | 35,794 (Direct) |
View |
2022-12-01 Exercise |
2022-12-02 4:05 pm |
N/A 2026-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
2,500 | $0 | 35,794 (Direct) |
View |
2022-12-01 Exercise |
2022-12-02 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
2,500 | $381.92 | 35,794 (Direct) |
View |
2022-11-22 Exercise |
2022-11-25 1:07 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
50,000 | $378.98 | 31,643 (Direct) |
View |
2022-11-22 Tax Withholding |
2022-11-25 1:07 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
38,028 | $741.81 | 31,643 (Direct) |
View |
2022-11-22 Exercise |
2022-11-25 1:07 pm |
N/A 2027-12-12 |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
50,000 | $0 | 31,643 (Direct) |
View |
2022-11-14 Exercise |
2022-11-16 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
10,000 | $179.13 | 61,400 (Direct) |
View |
2022-11-14 Exercise |
2022-11-16 4:01 pm |
N/A 2022-12-14 |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
10,000 | $0 | 61,400 (Direct) |
View |
2022-11-14 Gift |
2022-11-16 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
1,360 | $0 | 61,400 (Direct) |
View |
2022-11-14 Tax Withholding |
2022-11-16 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
6,280 | $746 | 61,400 (Direct) |
View |
2022-11-08 Exercise |
2022-11-10 4:00 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
1,564 | $482.68 | 14,793 (Direct) |
View |
2022-11-08 Exercise |
2022-11-10 4:00 pm |
N/A 2030-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
3,995 | $0 | 14,793 (Direct) |
View |
2022-11-08 Exercise |
2022-11-10 4:00 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
2,431 | $374.12 | 14,793 (Direct) |
View |
2022-11-04 Exercise |
2022-11-08 4:00 pm |
N/A 2026-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
34,000 | $0 | 31,643 (Direct) |
View |
2022-11-04 Tax Withholding |
2022-11-08 4:00 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
26,114 | $725.84 | 31,643 (Direct) |
View |
2022-11-04 Exercise |
2022-11-08 4:00 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
34,000 | $381.92 | 31,643 (Direct) |
View |
2022-11-04 Exercise |
2022-11-07 4:05 pm |
N/A 2029-12-11 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $0 | 30,732 (Direct) |
View |
2022-11-04 Exercise |
2022-11-07 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $372.46 | 30,732 (Direct) |
View |
2022-10-31 Tax Withholding |
2022-11-02 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
1,518 | $751.24 | 38,294 (Direct) |
View |
2022-10-31 Exercise |
2022-11-02 4:04 pm |
N/A 2026-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
2,000 | $0 | 38,294 (Direct) |
View |
2022-10-31 Exercise |
2022-11-02 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
2,000 | $381.92 | 38,294 (Direct) |
View |
2022-11-01 Exercise |
2022-11-02 4:03 pm |
N/A 2029-12-11 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $0 | 31,732 (Direct) |
View |
2022-11-01 Exercise |
2022-11-02 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $372.46 | 31,732 (Direct) |
View |
2022-10-14 Exercise |
2022-10-18 4:06 pm |
N/A 2026-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
1,500 | $0 | 40,294 (Direct) |
View |
2022-10-14 Tax Withholding |
2022-10-18 4:06 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
1,142 | $743.78 | 40,294 (Direct) |
View |
2022-10-14 Exercise |
2022-10-18 4:06 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
1,500 | $381.92 | 40,294 (Direct) |
View |
2022-10-03 Option Award |
2022-10-05 4:11 pm |
N/A 2032-10-03 |
REGENERON PHARMACEUTICALS INC. | REGN | Thompson Craig B. Director |
3,495 | $0 | 3,495 (Direct) |
View |
2022-10-03 Exercise |
2022-10-05 4:11 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
500 | $342.93 | 32,832 (Direct) |
View |
2022-10-03 Exercise |
2022-10-05 4:11 pm |
N/A 2028-02-12 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $0 | 32,832 (Direct) |
View |
2022-10-03 Exercise |
2022-10-05 4:11 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
600 | $372.46 | 32,832 (Direct) |
View |
2022-09-29 Exercise |
2022-10-03 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director |
10,838 | $413.33 | 12,921 (Direct) |
View |
2022-09-29 Exercise |
2022-10-03 4:05 pm |
N/A 2025-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director |
10,838 | $0 | 12,921 (Direct) |
View |
2022-09-09 Exercise |
2022-09-13 4:04 pm |
N/A 2025-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
40,000 | $0 | 31,643 (Direct) |
View |
2022-09-09 Tax Withholding |
2022-09-13 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
35,304 | $730.96 | 31,643 (Direct) |
View |
2022-09-09 Exercise |
2022-09-13 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
40,000 | $555.67 | 31,643 (Direct) |
View |